The below was received this morning. This wasn’t commissioned or paid for by the company. Important distinction compared to the typical conflicted paid Research-as-a-Service report many publish. Also worth noting some interesting U.S. buying and holders followed their initiation. Here's hoping that continues.
Jones Research updated with price target of $0.75
Radiopharm Theranostics (ASX:RAD), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to provide an updated research report from Jones Research.
Click below to view the full report:
The below was received this morning. This wasn’t commissioned or...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
-0.003(8.82%) |
Mkt cap ! $73.31M | |||
| Open | High | Low | Value | Volume |
| 3.4¢ | 3.4¢ | 3.1¢ | $58.95K | 1.821M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 783888 | 3.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.2¢ | 870662 | 1 |
View Market Depth
| Last trade - 16.10pm 19/09/2025 (20 minute delay) ? |
| RAD (ASX) Chart |